Disparities reported in use of cardioprotective drugs in type 2 diabetes
Healio: Sadeer Al-Kindi, associate professor at the School of Medicine, and his colleagues discussed new data that shows among adults with type 2 diabetes, white men and white women and those seeing an endocrinologist receive more prescriptions for SGLT2 inhibitors and GLP-1 receptor agonists than Black adults and those seen only in primary care. “Non-physician-driven prescriptions (e.g., pharmacy-driven prescribing and dose escalation) may improve utilization rates,” said the research team. “Multidisciplinary care delivery (e.g., comprehensive cardiometabolic centers) may additionally improve utilization rates.”
